Celator(R) Pharmaceuticals to Present at Third Annual Marcum MicroCap Conference
May 22, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., May 22, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals Announces Business Update and First Quarter 2014 Financial Results
May 12, 2014 16:01 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported business...
Celator(R) Pharmaceuticals Secures Loan Agreement With Hercules Technology Growth Capital
May 12, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014
May 05, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it...
Celator(R) Pharmaceuticals Announces Start of Clinical Study of CPX-351 in Relapsed/Refractory Higher Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients
March 26, 2014 16:01 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced...
Celator(R) Pharmaceuticals Announces Business Update and Fourth Quarter and Full Year 2013 Financial Results
March 24, 2014 16:01 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported...
Celator(R) Pharmaceuticals to Report Fourth Quarter and Year-End 2013 Financial Results on March 24, 2014
March 18, 2014 16:01 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., March 18, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals Announces New Date and Time for Presentation at 16th Annual BIO CEO and Investor Conference
February 03, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals to Present at Upcoming Healthcare Conferences
January 14, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals Reaches 50% Enrollment for CPX-351 Phase 3 Study
January 09, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...